Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage. Lee SW, Cho JM, Cho HJ, Kang JY, Kim EK, Yoo TK. Korean J Urol. 2015 Jul;56(7):505-14.
Comparison of Alfuzosin 10mg with or without propiverine 10mg, 20mg in men with lower urinary tract symptom and an overactive bladder: Randomized, Single-blind, Prospective study Cho HJ, shin SC, Seo DY, Cho JM, Kang JY, Yu JH, Sung LH, Moon HS, Yoo TK Int J Clin Pract. 2014 Jan 29. doi: 10.1111/ijcp.12339
Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability. Cho HJ, Yoo TK. Res Rep Urol. 2014 Sep 26;6:113-9.
Experience with robot-assisted laparoscopic radical prostatectomy at a secondary training hospital: operation time, treatment outcomes, and complications with the accumulation of experience. Seo do Y, Cho HJ, Cho JM, Kang JY, Yoo TK. Korean J Urol. 2013 Aug;54(8):522-6.
Efficacy of alfuzosin after shock wave lithotripsy for the treatment of ureteral calculi. Cho HJ, Shin SC, Seo do Y, Min DS, Cho JM, Kang JY, Yoo TK. Korean J Urol. 2013 Feb;54(2):106-10.
Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells. Kim SS, Cho HJ, Kang JY, Kang HK, Yoo TK. ScientificWorldJournal. 2013;2013:519397.
Benign prostatic hyperplasia: from bench to clinic. Yoo TK, Cho HJ. Korean J Urol. 2012 Mar;53(3):139-48
Safety and efficacy of combined transrectal ultrasound-guided prostate needle biopsy and transurethral resection of the prostate. Cho JM, Lee SW, Kang JY, Yoo TK. Korean J Urol. 2010 Feb;51(2):101-5.